| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| -1.86% | +2.08% | +56.29% | +122.52% | 1,165B | |
| -1.61% | +3.00% | +36.76% | +73.87% | 645B | |
| +0.03% | -0.16% | +24.85% | +96.89% | 504B | |
| -0.20% | +3.22% | +44.11% | +64.77% | 380B | |
| -1.60% | -0.96% | +65.81% | +39.87% | 363B | |
| -0.54% | +2.81% | +22.66% | +51.72% | 297B | |
| -1.66% | +2.64% | +2.22% | +26.48% | 269B | |
| -0.98% | +2.63% | +51.55% | +62.56% | 237B | |
| -0.29% | +0.65% | +30.21% | +102.69% | 195B | |
| Average | -0.95% | +2.54% | +37.16% | +71.26% | 450.61B | |
| Weighted average by Cap. | -1.29% | +3.17% | +41.40% | +82.76% |
Employees
4
Sector
Pharmaceuticals
